Sustainability & Climate

With new funding and a veteran biotech leader, Montreal's Find Therapeutics advances its first-in-class therapy aimed at reversing nerve damage in MS.

An expanded partnership aims to create next-gen cancer therapies by combining bispecific antibodies with two distinct drugs to overcome tumor resistance.

With a new board chair, regulatory backing, and an AI platform, GC Therapeutics is targeting MS and diabetes with next-generation cell therapies.

At CES 2026, Chinese startup KunlunMeta and AMD launched a portable AI terminal, promising unprecedented mobile productivity and data privacy.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

A major pharma giant is betting on artificial intelligence to accelerate cancer drug discovery, a move that could reshape the future of oncology treatment.

Making its CES debut, Chinese supplier InfiMotion unveiled next-gen electric drives that promise more power and efficiency in a lighter, integrated package.

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

A new report reveals shifting consumer demands for THCA flower, as the booming market grapples with quality standards and a complex regulatory future.

Chery Australia's new campaign does more than sell cars; it aims to drive tourism to regional Australia and redefine the classic family road trip.

Ventyx Biosciences is under investigation for misleading investors after a trial delay caused a 15% stock drop, even as a pharma giant moves to acquire it.

With a new CEO from Illumina and Exact Sciences, Quanterix signals a strategic shift from tech development to aggressive market and clinical expansion.

Savara's potential new therapy for autoimmune PAP, MOLBREEVI, gets a powerful partner in PANTHERx Rare, promising a new era of comprehensive patient care.

With 155 illnesses and hundreds of products recalled, a widespread Salmonella outbreak linked to pistachios has put Canada's food safety system to the test.

A new report shows minor Q4 gains, but with prices outpacing wages by nearly 2-to-1 over five years, the American dream of homeownership is fading fast.

Phoenix-based BioLab Holdings adds 37 professionals, bolstering R&D, quality, and compliance to drive innovation in a competitive medical landscape.

A historic $1 million estate gift launches Pink Fund's 20th anniversary, securing its future and highlighting the hidden financial burdens of breast cancer.

A new partnership merges a revolutionary centrifugal 3D printer with advanced materials, aiming to slash dental lab labor and cycle times by 90%.

The American Library Association marks its sesquicentennial with a year of celebration, highlighting its legacy and confronting a modern surge in censorship.

MiNK Therapeutics and UW–Madison launch a trial for an 'off-the-shelf' cell therapy, aiming to prevent deadly Graft-Versus-Host Disease (GvHD).